Sun Pharma faces heat from USFDA
After Ranbaxy Laboratories, another major Indian drug maker, Sun Pharmaceuticals, is under the United States Food and Drug Administration's scanner. The US drug regulator sent a warning letter to Caraco Pharmaceuticals, a US subsidiary of Sun Pharma, over the company's manufacturing facility in Detroit.
